Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

Clinical trial NCT04861077 · RECRUITING

Trial details

NCT number: NCT04861077
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2027-06-01
Primary completion: 2030-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.